Gene: NFE2L1
Official Full Name: NFE2 like bZIP transcription factor 1provided by HGNC
Gene Summary: This gene encodes a protein that is involved in globin gene expression in erythrocytes. Confusion has occurred in bibliographic databases due to the shared symbol of NRF1 for this gene, NFE2L1, and for "nuclear respiratory factor 1" which has an official symbol of NRF1. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06238 | NFE2L1 Knockout cell line (HeLa) | Human | NFE2L1 | 1:3~1:6 | Negative | Online Inquiry |
KO06239 | NFE2L1 Knockout cell line (HCT 116) | Human | NFE2L1 | 1:2~1:4 | Negative | Online Inquiry |
KO06240 | NFE2L1 Knockout cell line (HEK293) | Human | NFE2L1 | 1:3~1:6 | Negative | Online Inquiry |
KO06241 | NFE2L1 Knockout cell line (A549) | Human | NFE2L1 | 1:3~1:4 | Negative | Online Inquiry |
NFE2L1 Gene Knockout Cell Lines are genetically modified cellular models wherein the NFE2L1 gene has been selectively disrupted. NFE2L1, or Nuclear Factor, Erythroid 2 Like 1, encodes a transcription factor essential for cellular responses to oxidative stress and xenobiotic compounds. These cell lines serve as invaluable tools for investigating the implications of NFE2L1 deficiency on various biological processes, including cellular metabolism, inflammation, and response to oxidative stress.
The primary function of these knockout cell lines revolves around their ability to elucidate the pathways regulated by NFE2L1, which are critical for maintaining cellular homeostasis. By performing comparative analyses between knockout and wild-type cells, researchers can dissect the role of NFE2L1 in gene expression regulation and understand its contribution to disease mechanisms, particularly in cancer and age-related disorders. The developed cell lines are vital for screening potential therapeutic agents or investigating the efficacy of compounds that modulate the NFE2L1 pathway, making them essential in both basic and translational research.
In contrast to alternative models, such as transient knockdown approaches or complete organism models, NFE2L1 Gene Knockout Cell Lines offer several advantages. They provide a stable genetic background for long-term studies and reduce variability, facilitating reproducible experiments. Moreover, these models enable targeted investigations of gene-specific functions without the confounding effects seen in whole organisms.
For researchers and clinicians, these cell lines are precious resources designed to accelerate advancements in drug discovery, toxicological assessments, and the understanding of oxidative stress-related diseases. The ability to manipulate and study the NFE2L1 gene in a controlled environment empowers researchers to uncover potential therapeutic interventions that improve health outcomes.
Our company specializes in providing high-quality, validated biological models tailored to meet researchers' needs. We are committed to supporting the scientific community through innovative products that enhance understanding and advance clinical applications in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.